CHESTER, NY / ACCESSWIRE / April 17, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) ("RMS" or the "Company") announced today it has established a new medical advisory council. The members of this council are highly respected medical professionals and key opinion leaders in the immunology, allergy and immunodeficiency medical arena. The role of this council will be to advise the RMS Leadership Team in the area of research, product development, continual improvements, clinical studies and global expansion efforts. The council will also provide post marketing medical education to promote the safety and effectiveness of RMS' products and enhance the communications and networks between RMS, medical specialty pharmacy and nursing societies.
Members of the Medical Advisory Council are:
Dr. Robert Geng, Assistant Clinical Professor of Medicine and Pediatrics, University of California, San Diego.
Dr. Kelli Williams, Clinical Assistant Professor, Medical University of South Carolina Allergy & Immunology
Dr. Timothy Craig, Professor of Medicine and Pediatrics in Penn State University
All council members are currently involved in clinical practice and research (including intensive clinical studies) on allergy and immunology for adults and children with disorders of the immune system. With regards to their clinical research, they are working to bring novel and advanced therapies to adults/children with allergic and immunologic disorders. They are all active members of CIS, AAAAI, ESID, and IgNS.
Dr. Fred Ma, RMS Chief Medical Officer commented, "Our new Advisory Council is expected to play a key role in shaping the future success of RMS by opening many new channels within the medical professional community and all therapeutic societies domestically and internationally. They have great expectations that RMS will continue to innovate new products, drive continual improvements of existing product platforms and deliver solutions designed to improve the quality of life of their patients."
Dr. Geng commented, "It is so critical to understand the narrative across the entire immunotherapeutic field. The patient's wellbeing is always the first priority, which is not only dependent on the drugs we give to patients, but also relies heavily on the safety and efficacy of the drug delivery system."
RMS Medical Products is the leading manufacturer of medical products used for home infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60® and our latest FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo™ Subcutaneous Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company's RES-Q-VAC® line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers. The Company's website may be visited at www.rmsmedicalproducts.com.
This press release includes non-GAAP financial measures that are not in accordance with, nor an alternate to, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. They are limited in value because they exclude charges that have a material effect on our reported results and, therefore, should not be relied upon as the sole financial measures to evaluate our financial results. The non-GAAP financial measures are meant to supplement, and to be viewed in conjunction with, GAAP financial results. A reconciliation of our non-GAAP measures is included in an attachment to this press release.
For more information please call:
Mike King
(702) 650-3000
Princeton Research
SOURCE: RMS Medical Products